By 2022, the global Digital Pathology Market is anticipated to reach US$6,199 Mn, according to Future Market Insights. The market for digital pathology goods and services will increase at a CAGR of 13.5% during the projected period, reaching US$ 22,870.2 Mn by 2032.
Due to technological developments and the broad adoption of electronic medical records in the healthcare sector, digital pathology solutions are becoming more and more common. Cloud-based information systems are expected to expand at a CAGR of 16.9% through 2032, while on-premise systems will continue to dominate with US$ 626.8 Mn.
The rising use of advanced analytics in pharmaceutical and medical testing is one of the major drivers of the market for digital pathology. Analytics are being implemented by healthcare financing companies and governmental organisations through claim management and fraud prevention, which is driving the market’s expansion.
Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-124
Surge in R&D in Digital Pathology to Augment Sales in Forthcoming Years
The digital pathology market has expanded significantly as a result of the industry’s increased spending in biosimilar research and development projects, particularly for the treatment of cancer and Covid-19.
Pharmaceutical companies are entrusting regulatory consultants, in-vitro diagnostics (IVD) facilities, clinical laboratories, and contract research organisations (CROs) with the task of developing biosimilars. These businesses are growing to provide their clients more affordable solutions, necessitating the usage of digital pathology devices to diagnose, investigate, and create efficient healthcare solutions.
Cancer diagnostic Opens New Avenues for Digital Pathology Companies
Spending on digital pathology equipment is rising as a result of the sheer rise in cancer cases. When it comes to blood cancer and lung cancer in particular, complications from late cancer diagnosis entail the utilisation of considerable capital resources during treatment and diagnosis. The demand for these systems in the cancer research sector is being driven by the success of digital pathology in research. Government investors are being encouraged to invest in digital pathology systems for clinical diagnostics as a result of this. Cancer diagnosis and therapy monitoring involve large financial outlays. This explains why there is a huge need for digital pathology solutions.
Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-124
Competitive Landscape
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Huron Technologies International Inc.
- Koninklijke Philips N.V.
- Olympus Corporation
- Hamamatsu Photonics K.K.
- Carl Zeiss AG
- Nikon Corporation
- 3DHISTECH Ltd.
- Hologic Inc.
- PerkinElmer, Inc.
- Visiopharm
- OptraSCAN, Inc.
- Inspirata, Inc.
- Sectra AB
Some of the recent developments in digital pathology market are as follows:
- In May 2021, Leica Biosystems joined the European Society for Digital and Integrative Pathology (ESDIP) to assist pathology labs in developing laboratories in accordance with modern digital pathology instruments.
- In March 2021, Roche inked a comprehensive merger agreement with GenMark Diagnostics to broaden its product and distribution channel for European consumers.
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-124
Key Segments Profiled in the Global Digital Pathology Market
Digital Pathology by Product Type:
- Digital Pathology Equipment
- Whole Slide Scanners
- Brightfield Slide Scanners
- Fluorescence Slide Scanners
- Combination Slide Scanners
- Clinical Microscope
- Tissue Microarrays
- Whole Slide Scanners
- Digital Pathology Software
- Image Viewing and Analysis Software
- On-premise
- Cloud-based
- Image Viewing and Analysis Software
- Digital Pathology Information Systems
- On-premise
- Cloud-based
- Digital Pathology Services
- Installation and Integration Services
- Consulting Services
- Maintenance and Validation Services
Digital Pathology by Application:
- Clinical Pathology
- Molecular Diagnostics
- Basic & Applied Research
- Drug Development
- Others
Digital Pathology by End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Research Institutes
- Contract Research Organizations (CROs)
- Clinics
Use promo code ->> FMITODAY to get a flat 20% discount
Top Related Reports:
Negative Pressure Wound Therapy Market
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
